Stock Events

Stock Events

Search...

Brainstorm Cell Therapeutics (BCLI) Q3 2024 Earnings

14AugConfirmed

Q2 2023

Q3 2023

Q2 2024

Q3 2024

-0.53

-0.15

0.22

0.6

Details

Expected EPS

-0.525

Actual EPS

0.6

Surprise EPS

1.13

Surprise Percent

+214.29%

Description

Brainstorm Cell Therapeutics (BCLI) has reported earnings of 0.6 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.